59 results
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
in connection with this offering. We and the selling shareholders take no responsibility for, and can provide no assurance as to the reliability of, any other … be no assurance that the selling shareholders will sell any or all of the ADSs registered pursuant to this prospectus supplement.
The selling shareholders
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should … , but will not be obligated to do so and may discontinue any market making at any time without notice. We can make no assurance as to the liquidity
S-3ASR
EX-5.3
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.
On the basis
10-K
2023 FY
EX-31.2
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
License Agreement with Adaptimmune.”
We can provide no assurance that any of our current or future patent applications will result in issued patents … that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate
10-K
EX-31.1
uae2j
28 Feb 24
Annual report
7:33am
10-K
EX-10.14
fi39a oclek6wsks5
28 Feb 24
Annual report
7:33am
8-K
vv3pwj4gtczskjg29r7
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
6-K
EX-99.2
e76ic
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.2
ob5 sdlrai8xvopu17py
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
w5s959of0po7rtep9
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.2
rlp4eak54xvmqwt1
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
zq6 rz2zc1u
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
o9lwxd4ukh1z7ws4eqo
30 Sep 22
Prospectus with selling stockholder info
4:15pm
6-K
EX-1.1
h21k22i
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
502korlzr5
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
EX-99.2
mu9vcu7xq9xn6ievg7b0
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.2
z4gfa9te
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.2
z6ez 2l66ocziapo
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
424B7
au2 e6fpxe58io72fw
5 May 22
Prospectus with selling stockholder info
12:00am